Welcome to our dedicated page for QUANTUM X LABS SEC filings (Ticker: QXL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Quantum X Labs Inc. (QXL) SEC filings document the regulatory history of a Nasdaq-listed company formerly known as Viewbix Inc. The company’s 10-Q reports include consolidated financial statements prepared under U.S. GAAP, notes on wholly owned subsidiaries, business combination accounting, and acquisition-related disclosures involving Quantum X Labs Ltd. and Metagramm.
For QXL, quarterly reports and annual reports are important because the company’s identity combines several disclosed operating areas: quantum technology, digital advertising, computing, and enterprise AI solutions. Investors reviewing QXL 10-Q and 10-K filings can examine how the company presents consolidated subsidiaries, goodwill and intangible assets, business combinations, and technology-related disclosures tied to its operating structure.
Current reports on Form 8-K are also relevant for Quantum X Labs because the company has used them to report material events, including the acquisition of Quantum X Labs Ltd., pro forma financial information, officer appointments, and technology announcements related to neutral-atom quantum computing. Form 4 filings, when present, show insider transactions, while proxy materials can provide details on governance and compensation matters.
AI-powered summaries can make QXL filings easier to read by translating 10-Q, 10-K, 8-K, and Form 4 disclosures into plain-language explanations. Real-time EDGAR updates, simplified filing highlights, quarterly report summaries, annual report explanations, and insider transaction access are especially useful for a company whose filings connect acquisition history, software subsidiaries, and technical quantum programs.
QUANTUM X LABS INC. Co-CEO Baranes Yakov has filed an initial Form 3 to report his holdings in the company. He reports direct ownership of 106,790 shares of common stock.
He also holds a Pre-Funded Warrant that is exercisable into 246,387 shares of common stock at an exercise price of $0.0001 per share. According to the disclosure, these Pre-Funded Warrants will not expire until they are exercised in full. The filing does not show any new purchases or sales, only the positions he already holds.
Quantum X Labs Inc. filed a report describing the launch of its new 50+ physical qubit neutral-atom quantum computing platform that uses proprietary atom cooling and dynamically reconfigurable optical tweezer arrays. This architecture is designed to support rapid, high-fidelity qubit loading, extended coherence times, and high-performance Rydberg-mediated two-qubit gates.
The company states that its qubit strategy aims to reach thousands of qubits by the end of H1 2027. This roadmap relies on integrating a pending patented deep transformer decoder (US12294387B2), an AI-based error correction system coupled to the neutral-atom control stack to enable low-latency, syndrome-guided error correction and a pathway toward fault-tolerant logical qubit operations.
According to the disclosure, the platform is intended to strengthen Quantum X Labs’ broader quantum portfolio in computing, software and simulation, and sensing, and is aimed at advanced applications such as aerospace and defense, clinical trials, process optimization, nuclear energy, pharmaceuticals, and quantum cybersecurity.
Quantum X Labs Inc. appointed Yakov Baranes as co-Chief Executive Officer, effective May 18, 2026, alongside existing CEO Amihay Hadad, who will continue in a co-CEO structure. Baranes has 11 years of strategy experience across industries and government entities and has led Quantum X Labs Ltd., the company’s Israeli quantum-focused subsidiary, since March 2025.
Under a new agreement effective June 1, 2026, Baranes will receive a base salary of NIS 36,000 + VAT per month as co-CEO, plus NIS 24,000 + VAT per month for services to Quantum Israel, with eligibility for board-determined bonuses. The agreement is open-ended with a 60-day termination notice by either party, and immediate termination for cause is permitted.
In the March 2026 acquisition of Quantum Israel, Baranes, who previously held 32,647 shares (approximately 5.54%) of Quantum Israel, received 103,373 shares of common stock and pre-funded warrants to purchase 246,387 shares of Quantum X Labs common stock and may receive up to an additional 703,710 shares or pre-funded warrants upon achieving specified milestones.
Quantum X Labs Inc. Amendment No. 1 to a Schedule 13G/A reports that L.I.A. Pure Capital Ltd. beneficially owns 1,332,366 shares of common stock. The filing states this represents 9.99% of the class based on 13,336,392 shares outstanding as of the date hereof. The filing also notes that 7,079,877 Shares may be acquired within 60 days through exercise of warrants, subject to a blocker provision that limits exercise to prevent beneficial ownership above 4.99%. The amendment is signed by Kfir Silberman, Chief Executive Officer on 05/15/2026.
Capitalink Ltd. amended its Schedule 13G to report beneficial ownership in X Labs Inc. The filing states Capitalink beneficially owns 667,034 shares, representing 4.99% of X Labs' 13,336,392 shares outstanding used for the calculation. The filing counts 38,000 additional shares issuable upon exercise of warrants within 60 days and notes a 44,283-share warrant subject to a blocker provision.
X Labs Inc. filed an amendment to a Schedule 13G/A reporting beneficial ownership of 1,179,230 shares of Common Stock, representing 8.65% of the class. The filing states this percentage was calculated based on 13,336,392 shares outstanding as of the date hereof.
The filing explains the 1,179,230 figure consists of 879,230 Shares plus 300,000 Shares issuable upon conversion of a convertible loan. It also discloses additional potential shares tied to warrants: 44,283 Shares exercisable within 60 days and 300,000 Shares issuable upon conversion-related warrants, each subject to a blocker provision limiting exercises above 4.99%.
Quantum X Labs Inc. reported unaudited results for the quarter ended March 31, 2026, showing a small business focused on quantum technology and digital advertising that is still losing money. Revenue from continuing operations was $353 thousand, down from $529 thousand a year earlier, while net loss attributable to shareholders narrowed to $605 thousand from $3.7 million. Total assets rose to $27.7 million, mainly because of the March 4, 2026 acquisition of Quantum X Labs Ltd. in Israel, which added $14.3 million of goodwill and $1.2 million of in-process R&D.
Cash and cash equivalents were $1.8 million as of March 31, 2026, against bank loans of about $1.4 million and an accumulated deficit of $46.7 million. Management explicitly states that declining revenues, continued losses and reliance on external financing raise substantial doubt about the company’s ability to continue as a going concern, even after raising $1.4 million in a March 2026 private placement and completing its Nasdaq uplisting and earlier 2025 financings.
Quantum X Labs Inc. is providing audited 2025 financials and pro forma data for its March 4, 2026 acquisition of Quantum X Labs Ltd. in Israel. The acquired business generated no revenue in 2025, recorded a $325 thousand net loss and faces a going concern uncertainty due to ongoing losses and financing needs. Pro forma 2025 results combine $1.57 million of revenue with a $21.14 million net loss. The acquisition reflects a total purchase cost of $15.89 million, including a $10.67 million share and warrant consideration and a $5.22 million earn-out, creating $20.72 million of goodwill and $3.65 million of intangible assets on the combined balance sheet.